Given the vital role of CCL22 and its receptor CCR4 on Tregs recruitment and tumor progression,[18] we hypothesized that CCL22‐CCR4 axis was involved in SOX12‐induced Tregs enrichment. The gene discussed is CCL22; the disease is neoplasm.